r.mensa

TL2 · Vaasa

Contributes reviews on supplier material. Based in Vaasa.

Joined 18 June 2025 · last posted 11d · groups: regional-apac

83 posts, newest first. Showing up to 150.

What is genuinely unknown about long-term amylin agonism Replied, post #47 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2026 · 0 likes Amylin analogues affect gastric emptying as well, so the mechanism overlaps the incretins in at least one place. That overlap is part of why the combination's…
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #39 · Compounds › Secretagogues & GH axis · 14 Jul 2026 · 18 likes CJC-1295 exists in two forms in circulation — with and without the drug affinity complex — and they have very different half-lives. Product descriptions frequently do…
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #21 · Lounge › Off topic · 8 Jul 2026 · 4 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not. Adding the caveat now so it does not…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #110 · Evidence › Journal club · 4 Jul 2026 · 1 like Speaking only to orforglipron phase 2 as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests,…
Reading a syringe in poor light, and how to avoid needing to Replied, post #2 · marked as the solution · Devices › Syringes & needles · 1 Jul 2026 · 12 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
Asking a follow-up: new topic or new reply? Replied, post #18 · Start Here › How to Ask · 20 Jun 2026 · 21 likes Whatever the answer on asking a follow-up turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
External review after an internal denial Replied, post #3 · Access › Insurance & coverage · 16 Jun 2026 · 0 likes The opening post describes the usual case. This is about the unusual one. A peer-to-peer review is available in many systems and is frequently more productive than a…
A critique that turned out to be unfair, retracted by its author Replied, post #13 · Evidence › Study critique · 16 Jun 2026 · 0 likes Post #9 and I disagree about the size of the effect, not about the direction. Posting my critique numbers with the method attached so they can be discounted properly.…
An appeal that succeeded, with the letter structure — the long version Replied, post #84 · Access › Insurance & coverage · 11 Jun 2026 · 29 likes My position on appeal is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Prescription requirements and telehealth models — a second dataset Replied, post #58 · Sourcing › Regulatory · 8 Jun 2026 · 4 likes The documentation on Prescription requirements and telehealth models is better than this thread and I say that as someone who has posted in the thread.
Coming back to: Time to steady state after a dose increase Replied, post #68 · Pharmacology › Pharmacokinetics · 3 Jun 2026 · 15 likes The accumulation ratio for weekly dosing with a week-long half-life is around two, which is why the concentration after several doses is roughly double the…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #120 · Compounds › Tirzepatide · 3 Jun 2026 · 1 like Fine by me. I had wanted a stronger conclusion and there is not one available.
Molecular mass of semaglutide and why the figure differs between sources Replied, post #69 · Compounds › Semaglutide · 2 Jun 2026 · 3 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
Primary endpoint hierarchies and why order matters — one year on Replied, post #4 · Evidence › Trials · 31 May 2026 · 4 likes Answering the question the opening post raises rather than the one it answers. A treatment-policy estimand asks what happens to people assigned to a strategy, including…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #73 · Evidence › Journal club · 25 May 2026 · 12 likes Adding the measurement that post #72 says would settle it. An honest declaration on orforglipron phase 2: I have a prior here and it is strong enough that you should…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #19 · Analytics › Method validation · 12 May 2026 · 0 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
Anaesthesia and elective surgery: the aspiration question Replied, post #85 · Practice › Interactions · 13 Apr 2026 · 0 likes Where I would push back on the anaesthesia and elective surgery consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Official shortage notices and what they authorise Replied, post #5 · Access › Shortages · 12 Apr 2026 · 11 likes Regional differences during a shortage are large, and a supply position in one country says nothing about another. That much is documented. The rest is how I have…
Recording a dissent on a document rather than suppressing it Replied, post #11 · Documentation › Doc review · 12 Apr 2026 · 0 likes Taking post #10 at face value and following it one step further. A review date is a commitment rather than a formality, and a shorter cycle for a fast-moving subject is…
Anaesthesia and elective surgery: the aspiration question Replied, post #66 · Practice › Interactions · 28 Mar 2026 · 10 likes Post #64 describes the usual case. This is about the unusual one. Anaesthesia and elective surgery is well covered in the tag pages, and the older discussions are…
Managing an unplanned gap in supply Replied, post #62 · Access › Shortages · 16 Mar 2026 · 2 likes Narrowing post #59, because the general version has more than one answer. Filing a mild objection to the consensus on managing an unplanned gap. Mild because I might be…
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #48 · Compounds › Repair & healing peptides · 12 Mar 2026 · 0 likes Picking up post #45: that is the part I would want checked first. I would be cautious about generalising from the Reading a preclinical wound-healing model example…
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #43 · Practice › Storage & stability · 17 Feb 2026 · 0 likes Small correction to my own earlier position on Adsorptive losses. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
Adsorption to container surfaces and to plastics Replied, post #18 · Pharmacology › Formulation chemistry · 12 Feb 2026 · 5 likes Post #16 answers the question as asked. The question underneath it is different. Antioxidants: compounds that prevent oxidation (which damages peptides) are sometimes…
The headache that turns out to be dehydration Replied, post #151 · Nutrition & Training › Hydration & electrolytes · 23 Jan 2026 · 0 likes A note on scope: what I am saying about headache applies to the case in the first post and I would not extend it further without checking.
Foaming during reconstitution and whether it matters — the long version Replied, post #3 · Practice › Reconstitution · 5 Jan 2026 · 8 likes Noted, and I have changed what I was going to do on the strength of it.
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #66 · Wellbeing › Mental health · 22 Dec 2025 · 0 likes Taking post #65 at face value and following it one step further. Posting my Anxiety numbers with the method attached so they can be discounted properly. Uncontrolled,…
Tracking a preprint to publication: a worked example Replied, post #102 · Evidence › Preprints · 10 Dec 2025 · 12 likes Post #98 and I disagree about the size of the effect, not about the direction. Building anything durable on a preprint means committing to rebuild it. That is a…
Reading an interaction checker output critically Replied, post #54 · Practice › Interactions · 29 Nov 2025 · 8 likes Seconded. It reads as careful rather than confident, which is the right register.
High-resolution MS on aggregates and what it can see Replied, post #103 · Analytics › Mass spectrometry · 26 Oct 2025 · 3 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #12 · Compounds › Tirzepatide · 19 Oct 2025 · 0 likes The 2.5 mg starting dose is a tolerance step and not a therapeutic one. Judging efficacy at that dose is the single commonest reasoning error in this subcategory. I…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #5 · Compounds › Tirzepatide · 18 Oct 2025 · 4 likes This follows post #4 rather than contradicting it. Weight reduction figures from SURMOUNT-1 are frequently quoted without the trial's duration attached. A mean change…
Comparing my trajectory with the trial curves, carefully Replied, post #63 · Outcomes › Progress reports · 18 Oct 2025 · 13 likes A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats accuracy for a trend. I checked the source rather than the…
Power cut for eleven hours: how I assessed it afterwards Replied, post #91 · Practice › Storage & stability · 11 Oct 2025 · 1 like Coming back to post #89, because the follow-up matters more than the original answer. Power cut for eleven hours has a well-known answer and a correct answer, and the…
A parcel that arrived warm: a decision process, not a verdict Replied, post #70 · Practice › Storage & stability · 6 Oct 2025 · 25 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. Worth checking against a second source…
Documentation that appears only after payment Replied, post #39 · Sourcing › Red flags · 3 Oct 2025 · 29 likes A methods point on documentation rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
Adolescents: a distinct evidence base — one year on Replied, post #21 · Clinical › Special populations · 1 Oct 2025 · 0 likes I would call the community position on Adolescents likely rather than established, and I would be comfortable defending that hedge.
Insomnia at a dose step: reported experiences Replied, post #14 · Wellbeing › Sleep · 30 Sep 2025 · 2 likes Small methodological point on insomnia: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Needle changes between doses on a reusable pen Replied, post #38 · Devices › Pens & autoinjectors · 25 Sep 2025 · 1 like The instruction leaflet for a licensed pen is a genuinely good technical document and is almost never read past the first page. It answers most of what gets asked here.…
Hypertension improvement and when medication needs revisiting Replied, post #76 · Clinical › Comorbidities · 22 Sep 2025 · 0 likes The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about. The short answer was…
Which panel is worth repeating and which is worth ignoring Replied, post #96 · Clinical › Bloodwork · 28 Aug 2025 · 18 likes I read post #94 twice before replying, because I had assumed the opposite. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them…
Foaming during reconstitution and whether it matters Replied, post #24 · Practice › Reconstitution · 21 Aug 2025 · 21 likes Clear enough that I do not think I have a follow-up, which is unusual.
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #22 · Practice › Side effects · 7 Aug 2025 · 24 likes The arithmetic in post #20 is right; the assumption feeding it is the part to check. Nausea: the most common side effect and the most dose- and titration-dependent one.…
Triple agonism: additive, synergistic, or neither? Replied, post #76 · Compounds › Retatrutide · 6 Aug 2025 · 1 like On post #72 — agreed on the reasoning, with one qualification. Where the triple agonism reasoning breaks down for me is the step from the group result to the individual…
What a documentation review can and cannot tell you Replied, post #62 · Sourcing › Independent verification · 6 Aug 2025 · 1 like Adding a reference point for documentation review. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
Coming back to: Why quantitation is the hard part, not detection Replied, post #46 · Analytics › Home & field testing · 2 Aug 2025 · 0 likes Worth separating two things that post #42 runs together. Practical experience of quantitation, offered as one case with the conditions stated, not as a general finding.…
Titles that describe the question, not the situation Replied, post #61 · Start Here › How to Ask · 1 Aug 2025 · 5 likes One more thing on titles that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
Are there stupid questions here? A staff answer, at length Replied, post #23 · Start Here › Welcome · 29 Jul 2025 · 3 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #21 · Analytics › HPLC & UHPLC · 20 Jul 2025 · 3 likes Post #20 is the version of this I will quote in future. One addition. Injection volume matters because column overload distorts peak shape, and an overloaded main peak…
Coming back to: When "no data" is the complete and final answer Replied, post #47 · Compounds › Other compounds · 16 Jul 2025 · 26 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #13 · Compounds › Repair & healing peptides · 27 Jun 2025 · 9 likes Taking post #12 at face value and following it one step further. Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #88 · Nutrition & Training › Protein & intake · 14 Jun 2025 · 15 likes Confirming post #87 from a second method, which matters more than confirming it from a second person. Fibre and fluid tend to fall alongside protein when intake drops,…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #41 · Compounds › Oral incretins · 2 Jun 2025 · 15 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
Pre-registering a personal experiment, seriously Replied, post #83 · Research Methods › N-of-1 designs · 1 Jun 2025 · 1 like The failure mode on pre-registering a personal experiment is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #104 · Sourcing › Red flags · 31 May 2025 · 16 likes Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they do not establish anything on their own.
Validating a calculator against hand arithmetic — what changed since Replied, post #87 · Data & Tools › Calculators · 23 May 2025 · 0 likes Two questions I would want answered before drawing anything from the Validating a calculator against hand data above: how were the cases selected, and what happened to…
Journal club: SURMOUNT-1, read without the press release Replied, post #122 · Evidence › Journal club · 23 May 2025 · 13 likes Where the SURMOUNT-1 reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #8 · Sourcing › Regulatory · 20 May 2025 · 11 likes The practical version of compound being unapproved is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #42 · Compounds › Retatrutide · 13 May 2025 · 0 likes No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this compound is either a misreading or an invention, and the honest…
Residual solvents and scavengers: what is looked for Replied, post #22 · Analytics › Impurities & related substances · 10 May 2025 · 7 likes Aggregates may be a multiple of the monomer mass and may not elute at all under a standard method. What does not come off the column does not appear in the area…
A well-designed study with a badly written abstract Replied, post #41 · Evidence › Study critique · 24 Apr 2025 · 32 likes Speaking only to well-designed study as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #79 · Evidence › Journal club · 21 Apr 2025 · 29 likes On STEP 1 the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #42 · Compounds › Tirzepatide · 20 Apr 2025 · 25 likes Post #39 is the version of this I will quote in future. One addition. Comparisons between the tirzepatide and semaglutide programmes across trials rather than within…
Retatrutide dose escalation in the published trials Started this topic · Compounds › Retatrutide · 8 Mar 2025 · 3 likes Posting this under the heading it deserves: Retatrutide dose escalation in the published trials Everything below is what sits behind that. An honest uncertainty about…
Review: a draft on reconstitution arithmetic, with objections Replied, post #15 · Documentation › Doc review · 8 Feb 2025 · 12 likes Post #14 is right about the mechanism and I think understates the practical bit. Check the arithmetic in every worked example by hand. A wrong worked example is worse…
Food effects on oral incretin absorption: what is documented Started this topic · Compounds › Oral incretins · 31 Jan 2025 · 10 likes On the subject in the title: Food effects on oral incretin absorption: what is documented Working notes rather than a conclusion. Food effects on oral incretin, from…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #76 · Compounds › Other compounds · 29 Jan 2025 · 0 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
Distinguishing a deletion sequence by mass alone Started this topic · Analytics › Mass spectrometry · 17 Jan 2025 · 2 likes Distinguishing a deletion sequence by mass alone Writing it up because I had to work it out twice and would rather nobody else did. Trying to establish the boundary…
[2026 update] New subcategory: rationale and scope Replied, post #156 · Meta › Announcements · 17 Jan 2025 · 3 likes The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is about wording that no longer exists.
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #18 · Sourcing › Vendor reports · 30 Dec 2024 · 5 likes Bookmarking this. I will come back when I have something worth adding.
Building a sensible monitoring schedule with your prescriber Replied, post #34 · Clinical › Bloodwork · 19 Dec 2024 · 1 like Before the thread moves on from building a sensible monitoring schedule — what is the sample size behind the claim? I am not being difficult; I have seen the same…
Two sessions a week versus four: what the evidence supports Replied, post #24 · Nutrition & Training › Resistance training · 5 Dec 2024 · 10 likes Volume: the number of sets per muscle group per week that supports muscle maintenance is roughly 12 to 18 hard sets. That varies by individual but gives a target range.…
Coming back to: Why the cheapest option is often not the cheapest Replied, post #4 · Access › Pricing · 3 Dec 2024 · 1 like Cheapest option is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #55 · Clinical › Special populations · 24 Nov 2024 · 19 likes Confirming post #52 from a second method, which matters more than confirming it from a second person. Genetic and ancestry-related differences in response are asked…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #92 · Compounds › Repair & healing peptides · 19 Nov 2024 · 14 likes Nothing in this subcategory is medical advice and several members here are describing experiments on themselves. Both of those things should be stated plainly rather…
Why I ask for the gradient before I discuss the number Replied, post #33 · Analytics › HPLC & UHPLC · 4 Nov 2024 · 2 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #16 · Compounds › Secretagogues & GH axis · 16 Oct 2024 · 2 likes I disagree with the framing of pulsatile secretion above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be…
Requesting a page: what makes a good request — what changed since Replied, post #132 · Documentation › Wiki requests · 13 Oct 2024 · 2 likes A document with no maintainer becomes wrong quietly, which is worse than not existing, because it carries the authority of a maintained page.
Identical chromatograms across two different lots Replied, post #29 · Sourcing › Red flags · 25 Sep 2024 · 15 likes A document with no method identification is not evidence of anything wrong. It is evidence that the document cannot be checked, which is a different and weaker statement.
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #48 · Clinical › Bloodwork · 22 Sep 2024 · 0 likes Narrowing post #45, because the general version has more than one answer. The second most useful thing it does is say clearly when the answer is to book the…
Progressive overload when the scale is falling — one year on Replied, post #61 · Nutrition & Training › Resistance training · 16 Sep 2024 · 3 likes Strength and hypertrophy respond to different things, and preserving one during a deficit is a different objective from building the other. Stating my assumptions…
Merging two pages that cover the same ground — the long version Replied, post #5 · Documentation › Wiki requests · 11 Sep 2024 · 30 likes The arithmetic in post #2 is right; the assumption feeding it is the part to check. Where a request is for a translation or a regional version, the maintenance burden…
Coming back to: Purity assay versus content assay: two different numbers Replied, post #45 · Analytics › COA interpretation · 11 Aug 2024 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.